247.5p 0.5 0.2%
Last Trade - 3:31pm
| Market Cap | £530.4m |
| Enterprise Value | £476.1m |
| Revenue | £103.7m |
| Position in Universe | 537th / 1847 |
| Industry | Market | |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
| Year End 31st Dec | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | TTM | 2019E | 2020E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|---|
|
x
|
||||||||||
| Profitability | ||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
| Cashflow | ||||||||||
| Dividends | ||||||||||
| Balance Sheet | ||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing % | |||
| Net Gearing % | |||
| Cash / Assets % |
| Liquidity (ttm) | ||
|---|---|---|
| Curr. Ratio | ||
| Quick Ratio | ||
| Interest Cov. | ||
| Efficiency (ttm) | ||
|---|---|---|
| Asset Turnover | ||
| Recs Turnover | ||
| Stock Turnover | ||
| Latest interim period vs. prior period | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
| 3yr Compound Annual Growth Rate | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
Revenue
Net Income
Normalised EPS
PE Ratio Range
Dividend Yield Range
|
Price Target:
( below Price)
|
31st Dec 2019
|
31st Dec 2020
|
||||
|---|---|---|---|---|---|---|
| Est. Long Term Growth Rate: |
Net Profit () |
EPS () |
DPS () |
Net Profit () |
EPS () |
DPS () |
| Consensus Estimate | ||||||
| 1m Change | ||||||
| 3m Change | ||||||
Advanced Medical Solutions Group plc is engaged in the design, development, manufacture and distribution of materials for use in advanced woundcare products and surgical dressings, as well as medical adhesives and sutures for closing and sealing tissue. It operates through four segments: Branded Direct, Branded Distributed, OEM (Original Equipment Manufacturer) and Bulk Materials. Its Branded Direct segment is engaged in selling, marketing and innovation of its branded products sold directly by its sales teams. Its Branded Distributed segment is engaged in distribution, marketing and innovation of its brands sold by distributors in markets not serviced by its sales team. Its OEM segment is engaged in selling, marketing and innovation of its products supplied to partners under their brands. Its Bulk Materials segment is engaged in selling, marketing and innovation of bulk materials to medical device partners and convertors. Its products include ActivHeal, LiquiBand and RESORBA.
| Last Annual | December 31st, 2018 |
| Last Interim | June 30th, 2019 |
| Incorporated | November 1, 1993 |
| Public Since | April 30, 2002 |
| No. of Shareholders: | n/a |
| No. of Employees: | 654 |
| Sector | Healthcare |
| Industry | Healthcare Equipment & Supplies |
| Index | FTSE Aim All Share , FTSE Aim 100 , FTSE Intl-aim UK 50 , |
| Exchange | London Stock Exchange (Full) |
| Shares in Issue | 214,750,501 |
| Free Float | (0.0%) |
| Eligible for |
ISAs
SIPPs
|
| Address | Premier Park 33 Road One, WINSFORD, CW7 3RT, United Kingdom |
| Web | http://www.admedsol.com/ |
| Phone | +44 1606 863500 |
| Auditors | Deloitte LLP |
